Search
for
Sort by
Research 181–210 of 584
- Comprehensive Safety Exposure‐Response Analysis to Support Ritlecitinib Dose Selection
- Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Atopic Dermatitis and Multilocular Alopecia Areata Simultaneously Treated With Baricitinib
- Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib
- 0975 Single-cell transcriptomic profiling reveals distinct immunopathogenic programs in alopecia totalis/universalis compared to patchy alopecia areata
- Approach to Managing Recalcitrant Alopecia Areata with Combination Therapy: A Series of Five Cases in Black Pediatric Patients
- Review of Promising Off-Label Use of Deucravacitinib
- Wiederbehaarung bei einem Patienten mit Alopecia universalis und Psoriasis vulgaris unter Deucravacitinib‐Therapie
- USE OF RITLECITINIB FOR THE TREATMENT OF ALOPECIA AREATA
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- The JAK/STAT signaling pathway: from bench to clinic
- The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Application of Baricitinib in Dermatology
- Mechanisms of autophagy and their implications in dermatological disorders
- Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review
- Seborrheic Dermatitis Revisited: Pathophysiology, Diagnosis, and Emerging Therapies—A Narrative Review
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- Delayed granulomatous eruption of the nose associated with ruxolitinib
- Clinical and Genetic Aspects of Alopecia Areata: A Cutting Edge Review
- Peripheral neuropathy associated with tofacitinib use in alopecia universalis
- Vitiligo—Current Treatment Options and Future Perspectives
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Exploring novel management options for alopecia areata